Copy Number Variation and Osteoporosis

Abstract

Purpose of Review The purpose of this review is to summarize recent findings on copy number variations and susceptibility to osteoporosis. Recent Findings Osteoporosis is highly influenced by genetic factors, including copy number variations (CNVs). The development and accessibility of whole genome sequencing methods has accelerated the study of CNVs and osteoporosis. Recent findings include mutations in novel genes and validation of previously known pathogenic CNVs in monogenic skeletal diseases. Identification of CNVs in genes previously associated with osteoporosis (e.g. RUNX2, COL1A2, and PLS3) has confirmed their importance in bone remodelling. This process has been associated also with the ETV1-DGKB, AGBL2, ATM, and GPR68 genes, identified by comparative genomic hybridisation microarray studies. Importantly, studies in patients with bone pathologies have associated bone disease with the long non-coding RNA LINC01260 and enhancer sequences residing in the HDAC9 gene. Summary Further functional investigation of genetic loci harbouring CNVs associated with skeletal phenotypes will reveal their role as molecular drivers of osteoporosis.

Targeting Mitophagy as a Potential Therapeutic Approach for Age‐Related Bone Diseases

“…[7] More importantly, there is mounting proof that mitochondria play a pivotal role in bone homeostasis and aging. [8] Mitochondrial dysfunction, considered one of the hallmarks of aging, [9] is commonly identified in various agerelated disorders, including diabetes, [10] Parkinson's disease, [11] Alzheimer's disease (AD), [12] osteoporosis, [13] and periodontitis (PD). [14] Mitochondrial dysfunction manifests as reduced mitochondrial biogenesis, abnormal metabolism, oxidative stress, morphological changes, and disrupted mitochondrial dynamics.…”

Anaphase-Promoting Complex Subunit 1 Associates with Bone Mineral Density in Human Osteoporotic Bone

“…With the ageing of the population, the number of fractures is expected to increase sharply in the coming years. The search for new potential biomarkers of osteoporosis will allow better targeting of those most at risk [ 2 , 3 , 4 ]. Osteoporosis is mainly determined by low bone mineral density (BMD) and is highly heritable [ 5 ].…”